SVB Securities analyst Andrew Berens downgraded Seagen to Market Perform from Outperform with a $141 price target.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on SGEN:
- Truist sees potential pressure on Seagen’s Padcev in Q4
- Seagen price target lowered to $170 from $183 at Berenberg
- Biotech Alert: Searches spiking for these stocks today
- Seagen label for Tukysa in CRC broader-than-expected, says William Blair
- Seagen announces FDA accelerated approval of TUKYSA-trastuzumab combo